Paper
0
803 Anti-tumor activity of RAS(ON) multi-selective inhibitor RMC-6236 and anti-PD-1 combination in immunologically heterogeneous preclinical PDAC models
Authors
Published
Nov 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.